SEC Form 4 · accession 0001209191-15-014549

· CELG

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Mark J Alles

Officer — See Remarks

Period of report

Feb 12, 2015

Accepted (ET)

Feb 17, 2015 · 4:44 pm EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000816284

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Feb 12, 2015	M	573	$27.275	A	74,213	D
Common Stock	Feb 12, 2015	M	1,478	$74.30	A	75,691	D
Common Stock	Feb 12, 2015	M	148	$30.74	A	75,839	D
Common Stock	Feb 12, 2015	M	430	$26.17	A	76,269	D
Common Stock	Feb 12, 2015	M	860	$28.94	A	77,129	D
Common Stock	Feb 12, 2015	M	5,333	$29.75	A	82,462	D
Common Stock	Feb 12, 2015	M	430	$25.765	A	82,892	D
Common Stock	Feb 12, 2015	M	1,562	$36.96	A	84,454	D
Common Stock	Feb 12, 2015	M	1,040	$36.465	A	85,494	D
Common Stock	Feb 12, 2015	M	2,081	$34.70	A	87,575	D
Common Stock	Feb 12, 2015	M	2,081	$36.675	A	89,656	D
Common Stock	Feb 12, 2015	M	4,375	$40.22	A	94,031	D
Common Stock	Feb 12, 2015	M	1,040	$49.475	A	95,071	D
Common Stock	Feb 12, 2015	M	1,478	$59.235	A	96,549	D
Common Stock	Feb 12, 2015	M	1,478	$71.33	A	98,027	D
Common Stock	Feb 12, 2015	M	1,478	$78.115	A	99,505	D
Common Stock	Feb 12, 2015	M	1,640	$81.555	A	101,145	D
Common Stock	holding	—	—		—	5,639	I	401(k) Plan

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (right to buy)^F2,F1	$27.275	Feb 12, 2015	M	573	D	—	Oct 13, 2019	Common Stock	573	0	D
Stock Option (right to buy)^F2,F1	$74.30	Feb 12, 2015	M	1,478	D	—	Feb 3, 2024	Common Stock	1,478	11,824	D
Stock Option (right to buy)^F2,F1	$30.74	Feb 12, 2015	M	148	D	—	Apr 13, 2020	Common Stock	148	0	D
Stock Option (right to buy)^F2,F1	$26.17	Feb 12, 2015	M	430	D	—	Jul 13, 2020	Common Stock	430	0	D
Stock Option (right to buy)^F2,F1	$28.94	Feb 12, 2015	M	860	D	—	Oct 12, 2020	Common Stock	860	0	D
Stock Option (right to buy)^F2,F1	$29.75	Feb 12, 2015	M	5,333	D	—	Dec 27, 2020	Common Stock	5,333	0	D
Stock Option (right to buy)^F2,F1	$25.765	Feb 12, 2015	M	430	D	—	Jan 31, 2021	Common Stock	430	0	D
Stock Option (right to buy)^F2,F1	$36.96	Feb 12, 2015	M	1,562	D	—	Mar 1, 2022	Common Stock	1,562	8,290	D
Stock Option (right to buy)^F2,F1	$36.465	Feb 12, 2015	M	1,040	D	—	Apr 30, 2022	Common Stock	1,040	8,326	D
Stock Option (right to buy)^F2,F1	$34.70	Feb 12, 2015	M	2,081	D	—	Jul 30, 2022	Common Stock	2,081	8,326	D
Stock Option (right to buy)^F2,F1	$36.675	Feb 12, 2015	M	2,081	D	—	Oct 31, 2022	Common Stock	2,081	8,326	D
Stock Option (right to buy)^F2,F1	$40.22	Feb 12, 2015	M	4,375	D	—	Dec 17, 2022	Common Stock	4,375	17,500	D
Stock Option (right to buy)^F2,F1	$49.475	Feb 12, 2015	M	1,040	D	—	Jan 28, 2023	Common Stock	1,040	10,468	D
Stock Option (right to buy)^F2,F1	$59.235	Feb 12, 2015	M	1,478	D	—	Apr 29, 2023	Common Stock	1,478	17,738	D
Stock Option (right to buy)^F2,F1	$71.33	Feb 12, 2015	M	1,478	D	—	Jul 29, 2023	Common Stock	1,478	11,824	D
Stock Option (right to buy)^F2,F1	$78.115	Feb 12, 2015	M	1,478	D	—	Oct 28, 2023	Common Stock	1,478	11,824	D
Stock Option (right to buy)^F2,F1	$81.555	Feb 12, 2015	M	1,640	D	—	Dec 2, 2023	Common Stock	1,640	13,124	D

Explanation of responses

F1The option was fully exercisable.
F2The option was issued pursuant to the Celgene Corporation 2008 Stock Incentive Plan (Amended and Restated as of April 17, 2013).

Remarks

President and Chief Operating Officer